Mediastinal metastasis of glioblastoma multiforme evolving from anaplastic astrocytoma

By Tuominen Hannu   Lohi Jouni   Maiche Abdel   Törmänen Juhani   Baumann Peter  

Journal of Neuro-Oncology, Vol. 75, Iss. 2, 2005-11 ,pp. : 225-226

Springer Publishing Company

Access to resources Recommend Favorite

A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma

By Pipas J.   Meyer Louise   Rhodes C.   Cromwell Laurence   McDonnell Carol   Kingman Linda   Rigas James   Fadul Camilo  

Journal of Neuro-Oncology, Vol. 71, Iss. 3, 2005-02 ,pp. : 301-305

Springer Publishing Company

Access to resources Recommend Favorite

A phase I trial of surgery, Gliadel wafer implantation, and immediate postoperative carboplatin in combination with radiation therapy for primary anaplastic astrocytoma or glioblastoma multiforme

By Limentani Steven   Asher Anthony   Heafner Michael   Kim Joseph   Fraser Robert  

Journal of Neuro-Oncology, Vol. 72, Iss. 3, 2005-05 ,pp. : 241-244

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant cisplatin plus temozolomide versus standard treatment in patients with unresectable glioblastoma or anaplastic astrocytoma: a differential effect of MGMT methylation

By Capdevila Laia   Cros Sara   Ramirez Jose-Luis   Sanz Carolina   Carrato Cristina   Romeo Margarita   Etxaniz Olatz   Hostalot Cristina   Massuet Ana   Cuadra Jose   Villà Salvador   Balañà Carmen  

Journal of Neuro-Oncology, Vol. 117, Iss. 1, 2014-03 ,pp. : 77-84

Springer Publishing Company

Access to resources Recommend Favorite

Correlation between SATB1 and Bcl-2 expression in human glioblastoma multiforme

By          

Molecular Medicine Reports, Vol. 7, Iss. 1, 2013-01 ,pp. : 139-143

Spandidos Publications

Access to resources Recommend Favorite